- Home
- INR vs TXMD Comparison
INR vs TXMD Comparison
Compare INR & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INR
- TXMD
- Stock Information
- Founded
- INR 2017
- TXMD 2008
- Country
- INR United States
- TXMD United States
- Employees
- INR N/A
- TXMD N/A
- Industry
- INR
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- INR
- TXMD Health Care
- Exchange
- INR NYSE
- TXMD Nasdaq
- Market Cap
- INR 295.3M
- TXMD 12.8M
- IPO Year
- INR 2025
- TXMD N/A
- Fundamental
- Price
- INR $16.70
- TXMD $1.18
- Analyst Decision
- INR Strong Buy
- TXMD
- Analyst Count
- INR 7
- TXMD 0
- Target Price
- INR $27.43
- TXMD N/A
- AVG Volume (30 Days)
- INR 379.0K
- TXMD 45.8K
- Earning Date
- INR 08-11-2025
- TXMD 08-11-2025
- Dividend Yield
- INR N/A
- TXMD N/A
- EPS Growth
- INR N/A
- TXMD N/A
- EPS
- INR 1.89
- TXMD N/A
- Revenue
- INR $293,962,000.00
- TXMD $1,841,000.00
- Revenue This Year
- INR $49.00
- TXMD $427.09
- Revenue Next Year
- INR $16.39
- TXMD N/A
- P/E Ratio
- INR $8.52
- TXMD N/A
- Revenue Growth
- INR 62.18
- TXMD 53.55
- 52 Week Low
- INR $13.64
- TXMD $0.70
- 52 Week High
- INR $23.00
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- INR N/A
- TXMD 48.98
- Support Level
- INR N/A
- TXMD $0.98
- Resistance Level
- INR N/A
- TXMD $1.21
- Average True Range (ATR)
- INR 0.00
- TXMD 0.09
- MACD
- INR 0.00
- TXMD 0.01
- Stochastic Oscillator
- INR 0.00
- TXMD 80.00
About INR INFINITY NATURAL RESOURCES INC
Infinity Natural Resources Inc is an oil and natural gas exploration and production company. The group focused on developing unconventional reserves in Appalachia. The company is engaged in acquiring, exploring, producing, and developing properties for producing oil, natural gas, and natural gas liquids (NGLs) from underground reservoirs.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.